Document:

Form of Common Stock Warrant Agreement and Warrant Certificate

 EXHIBIT 4.4 
 KOSAN BIOSCIENCES INCORPORATED 
 and 
                     , AS WARRANT AGENT 
 FORM OF COMMON STOCK 
 WARRANT
AGREEMENT 
 DATED AS OF
                     

 KOSAN BIOSCIENCES INCORPORATED 
 FORM OF COMMON STOCK WARRANT AGREEMENT 
 COMMON
STOCK WARRANT AGREEMENT (this “Agreement”), dated as of                     
between KOSAN BIOSCIENCES INCORPORATED, a Delaware corporation (the “Company”) and
                    , a [corporation] [national banking association] organized and existing under the laws of
                     and having a corporate trust office in
                    , as warrant agent (the “Warrant Agent”). 
 WHEREAS, the Company proposes to sell [if Warrants are sold with common stock — Common Stock of the Company,
par value $.001 per share (the “Common Stock”) with] warrant certificates evidencing one or more warrants (the “Warrants” or, individually, a “Warrant”) representing the right to purchase [Common Stock][ Common Stock of
the Company, par value $.001 per share (the “Common Stock”)] (the “Warrant Securities”), such warrant certificates and other warrant certificates issued pursuant to this Agreement being herein called the “Warrant
Certificates”; and 
 WHEREAS, the Company desires the Warrant Agent to act on behalf of the
Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other things, the form and
provisions of the Warrant Certificates and the terms and conditions on which they may be issued, registered, transferred, exchanged, exercised and replaced. 
 NOW THEREFORE, in consideration of the premises and of the mutual agreements herein contained, the parties hereto agree as follows: 
 ARTICLE 1 
 ISSUANCE OF WARRANTS AND
EXECUTION AND DELIVERY OF WARRANT CERTIFICATES 
 1.1 Issuance Of Warrants. [If Warrants alone—Upon issuance, each Warrant
Certificate shall evidence one or more Warrants.] [If Common Stock and Warrants—Warrant Certificates shall be [initially] issued in connection with the issuance of the Common Stock [but shall be separately transferable on and after
                     (the “Detachable Date”)] [and shall not be separately transferable] and each Warrant Certificate shall
evidence one or more Warrants.] Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and therein, to purchase one Warrant Security. [If Common Stock and Warrants—Warrant Certificates shall be
initially issued in units with the Common Stock and each Warrant Certificate included in such a unit shall evidence
                     Warrants for each
[                    ] shares of Common Stock included in such unit.] 
  

 . 

 1.2 Execution And Delivery Of Warrant Certificates. Each Warrant Certificate, whenever issued,
shall be in registered form substantially in the form set forth in Exhibit A hereto, shall be dated the date of its countersignature by the Warrant Agent and may have such letters, numbers, or other marks of identification or designation and such
legends or endorsements printed, lithographed or engraved thereon as the officers of the Company executing the same may approve (execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions of this
Agreement, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which the Warrants may be listed, or to conform to usage. The Warrant
Certificates shall be signed on behalf of the Company by any of its present or future chief executive officers, presidents, senior vice presidents, vice presidents, chief financial officers, chief legal officers, treasurers, assistant treasurers,
controllers, assistant controllers, secretaries or assistant secretaries under its corporate seal reproduced thereon. Such signatures may be manual or facsimile signatures of such authorized officers and may be imprinted or otherwise reproduced on
the Warrant Certificates. The seal of the Company may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant Certificates. 
 No Warrant Certificate shall be valid for any purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been
countersigned by the manual signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed by the Company shall be conclusive evidence that the Warrant Certificate so countersigned has been duly issued
hereunder. 
 In case any officer of the Company who shall have signed any of the Warrant Certificates either manually or by facsimile
signature shall cease to be such officer before the Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent, such Warrant Certificates may be countersigned and delivered notwithstanding that the person who
signed Warrant Certificates ceased to be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Warrant Certificate, shall be the proper
officers of the Company, although at the date of the execution of this Agreement any such person was not such officer. 
 The term
“holder” or “holder of a Warrant Certificate” as used herein shall mean any person in whose name at the time any Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose [If
Common Stock and Warrants are not immediately detachable—or upon the registration of the Common Stock prior to the Detachable Date. Prior to the Detachable Date, the Company will, or will cause the registrar of the Common Stock to, make
available at all times to the Warrant Agent such information as to holders of the Common Stock as may be necessary to keep the Warrant Agent’s records up to date]. 
 1.3 Issuance Of Warrant Certificates. Warrant Certificates evidencing the right to purchase Warrant Securities may be executed by the Company and delivered to the Warrant Agent upon the execution of this
Warrant Agreement or from time to time thereafter. The Warrant Agent shall, upon receipt of Warrant Certificates duly executed on behalf of the Company, countersign such Warrant Certificates and shall deliver such Warrant Certificates to or upon the
order of the Company. 

 ARTICLE 2 
 WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS 
 2.1 Warrant Price. During the period
specified in Section 2.2, each Warrant shall, subject to the terms of this Warrant Agreement and the applicable Warrant Certificate, entitle the holder thereof to purchase the number of Warrant Securities specified in the applicable Warrant
Certificate at an exercise price of $             per Warrant Security, subject to adjustment upon the occurrence of certain events, as hereinafter provided. Such purchase price
per Warrant Security is referred to in this Agreement as the “Warrant Price.” 
 2.2 Duration Of Warrants. Each Warrant may
be exercised in whole or in part at any time, as specified herein, on or after [the date thereof] [            ] and at or before
[        ] p.m., [City] time, on                  or such later date as the Company may designate by
notice to the Warrant Agent and the holders of Warrant Certificates mailed to their addresses as set forth in the record books of the Warrant Agent (the “Expiration Date”). Each Warrant not exercised at or before
[        ] p.m., [City] time, on the Expiration Date shall become void, and all rights of the holder of the Warrant Certificate evidencing such Warrant under this Agreement shall cease.

 2.3 Exercise Of Warrants. 
 (a) During the period specified in Section 2.2, the Warrants may be exercised to purchase a whole number of Warrant Securities in registered form by providing certain information as set forth on the
reverse side of the Warrant Certificate and by paying in full, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available
funds] the Warrant Price for each Warrant Security with respect to which a Warrant is being exercised to the Warrant Agent at its corporate trust office, provided that such exercise is subject to receipt within five business days of such payment by
the Warrant Agent of the Warrant Certificate with the form of election to purchase Warrant Securities set forth on the reverse side of the Warrant Certificate properly completed and duly executed. The date on which payment in full of the Warrant
Price is received by the Warrant Agent shall, subject to receipt of the Warrant Certificate as aforesaid, be deemed to be the date on which the Warrant is exercised; provided, however, that if, at the date of receipt of such Warrant Certificates and
payment in full of the Warrant Price, the transfer books for the Warrant Securities purchasable upon the exercise of such Warrants shall be closed, no such receipt of such Warrant Certificates and no such payment of such Warrant Price shall be
effective to constitute the person so designated to be named as the holder of record of such Warrant Securities on such date, but shall be effective to constitute such person as the holder of record of such Warrant Securities for all purposes at the
opening of business on the next succeeding day on which the transfer books for the Warrant Securities purchasable upon the exercise of such Warrants shall be opened, and the certificates for the Warrant Securities in respect of which such Warrants
are then exercised shall be issuable as of the date on such next succeeding day on which the transfer books shall next be opened, and until such date the Company shall be under no duty to deliver any certificate for such Warrant Securities. The
Warrant Agent shall deposit all funds received by it in payment of the Warrant Price in an account of the Company maintained with it and shall advise the Company by 

 
telephone at the end of each day on which a payment for the exercise of Warrants is received of the amount so deposited to its account. The Warrant Agent
shall promptly confirm such telephone advice to the Company in writing. 
 (b) The Warrant Agent shall, from time to
time, as promptly as practicable, advise the Company of (i) the number of Warrant Securities with respect to which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates evidencing such Warrants with
respect to delivery of the Warrant Securities to which such holder is entitled upon such exercise, (iii) delivery of Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Securities after such exercise,
and (iv) such other information as the Company shall reasonably require. 
 (c) As soon as practicable after the
exercise of any Warrant, the Company shall issue to or upon the order of the holder of the Warrant Certificate evidencing such Warrant the Warrant Securities to which such holder is entitled, in fully registered form, registered in such name or
names as may be directed by such holder. If fewer than all of the Warrants evidenced by such Warrant Certificate are exercised, the Company shall execute, and an authorized officer of the Warrant Agent shall manually countersign and deliver, a new
Warrant Certificate evidencing Warrants for the number of Warrant Securities remaining unexercised. 
 (d) The Company
shall not be required to pay any stamp or other tax or other governmental charge required to be paid in connection with any transfer involved in the issue of the Warrant Securities, and in the event that any such transfer is involved, the Company
shall not be required to issue or deliver any Warrant Security until such tax or other charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due. 
 (e) Prior to the issuance of any Warrants there shall have been reserved, and the Company shall at all times through the Expiration
Date keep reserved, out of its authorized but unissued Warrant Securities, a number of shares sufficient to provide for the exercise of the Warrants. 
 ARTICLE 3 
 OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS OF WARRANT CERTIFICATES 

3.1 No Rights As Warrant Securityholder Conferred By Warrants Or Warrant Certificates. No Warrant Certificate or Warrant evidenced thereby
shall entitle the holder thereof to any of the rights of a holder of Warrant Securities, including, without limitation, the right to receive the payment of dividends or distributions, if any, on the Warrant Securities or to exercise any voting
rights, except to the extent expressly set forth in this Agreement or the applicable Warrant Certificate. 
 3.2 Lost, Stolen, Mutilated
Or Destroyed Warrant Certificates. Upon receipt by the Warrant Agent of evidence reasonably satisfactory to it and the Company of the ownership of and the loss, theft, destruction or mutilation of any Warrant Certificate and/or indemnity 

 
reasonably satisfactory to the Warrant Agent and the Company and, in the case of mutilation, upon surrender of the mutilated Warrant Certificate to the
Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an authorized officer of the Warrant Agent
shall manually countersign and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate, a new Warrant Certificate of the same tenor and evidencing Warrants for a like number of Warrant Securities. Upon the
issuance of any new Warrant Certificate under this Section 3.2, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the
fees and expenses of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered pursuant to this Section 3.2 in lieu of any lost, stolen or destroyed Warrant Certificate shall represent an additional
contractual obligation of the Company, whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by anyone, and shall be entitled to the benefits of this Agreement equally and proportionately with any and all
other Warrant Certificates duly executed and delivered hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement of mutilated, lost,
stolen or destroyed Warrant Certificates. 
 3.3 Holder Of Warrant Certificate May Enforce Rights. Notwithstanding any of the
provisions of this Agreement, any holder of a Warrant Certificate, without the consent of the Warrant Agent, the holder of any Warrant Securities or the holder of any other Warrant Certificate, may, in such holder’s own behalf and for such
holder’s own benefit, enforce, and may institute and maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, such holder’s right to exercise the Warrants evidenced by such holder’s
Warrant Certificate in the manner provided in such holder’s Warrant Certificate and in this Agreement. 
 3.4 Adjustments.

 (a) In case the Company shall at any time subdivide its outstanding shares of Common Stock into a greater number
of shares, the Warrant Price in effect immediately prior to such subdivision shall be proportionately reduced and the number of Warrant Securities purchasable under the Warrants shall be proportionately increased. Conversely, in case the outstanding
shares of Common Stock of the Company shall be combined into a smaller number of shares, the Warrant Price in effect immediately prior to such combination shall be proportionately increased and the number of Warrant Securities purchasable under the
Warrants shall be proportionately decreased. 
 (b) If at any time or from time to time the holders of Common Stock (or
any shares of stock or other securities at the time receivable upon the exercise of the Warrants) shall have received or become entitled to receive, without payment therefore, 
 (i) Common Stock or any shares of stock or other securities which are at any time directly or indirectly convertible into or
exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution; 

 (ii) any cash paid or payable otherwise than as a cash dividend paid or payable
out of the Company’s current or retained earnings; 
 (iii) any evidence of the Company’s indebtedness or
rights to subscribe for or purchase the Company’s indebtedness; or 
 (iv) Common Stock or additional stock or
other securities or property (including cash) by way of spinoff, split-up, reclassification, combination of shares or similar corporate rearrangement (other than shares of Common Stock issued as a stock split or adjustments in respect of which shall
be covered by the terms of Section 3.4(a) above), then and in each such case, the holder of each Warrant shall, upon the exercise of the Warrant, be entitled to receive, in addition to the number of Warrant Securities receivable thereupon, and
without payment of any additional consideration therefore, the amount of stock and other securities and property (including cash and indebtedness or rights to subscribe for or purchase indebtedness) which such holder would hold on the date of such
exercise had he been the holder of record of such Warrant Securities as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property. 
 (c) In case of (i) any reclassification, capital reorganization, or change in the Common Stock of the Company (other than as a
result of a subdivision, combination, or stock dividend provided for in Section 3.4(a) or Section 3.4(b) above), (ii) share exchange, merger or similar transaction of the Company with or into another person or entity (other than a
share exchange, merger or similar transaction in which the Company is the acquiring or surviving corporation and which does not result in any change in the Common Stock other than the issuance of additional shares of Common Stock) or (iii) the
sale, exchange, lease, transfer or other disposition of all or substantially all of the properties and assets of the Company as an entirety (in any such case, a “Reorganization Event”), then, as a condition of such Reorganization Event,
lawful provisions shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to the holders of the Warrants, so that the holders of the Warrants shall have the right at any time prior to the
expiration of the Warrants to purchase, at a total price equal to that payable upon the exercise of the Warrants, the kind and amount of shares of stock and other securities and property receivable in connection with such Reorganization Event by a
holder of the same number of Warrant Securities as were purchasable by the holders of the Warrants immediately prior to such Reorganization Event. In any such case appropriate provisions shall be made with respect to the rights and interests of the
holders of the Warrants so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise the Warrants, and appropriate adjustments shall be made to the
Warrant Price payable hereunder provided the aggregate purchase price shall remain the same. In the case of any transaction described in clauses (ii) and (iii) above, the Company shall thereupon be relieved of any further obligation
hereunder or under the Warrants, and the Company as the predecessor corporation may thereupon or at any time thereafter be dissolved, wound up or liquidated. Such successor or assuming entity thereupon may cause to be signed, and may issue either in
its own name or in the name of the Company, any or all of the Warrants issuable hereunder which heretofore shall not have been signed by the Company, and may execute and deliver securities in its own name, in fulfillment of its obligations to
deliver Warrant Securities upon exercise of the Warrants. All the Warrants so issued shall in all respects have the same legal rank and benefit under this 

 
Agreement as the Warrants theretofore or thereafter issued in accordance with the terms of this Agreement as though all of such Warrants had been issued at
the date of the execution hereof. In any case of any such Reorganization Event, such changes in phraseology and form (but not in substance) may be made in the Warrants thereafter to be issued as may be appropriate. 
 The Warrant Agent may receive a written opinion of legal counsel as conclusive evidence that any such Reorganization Event complies with the provisions
of this Section 3.4. 
 (d) The Company may, at its option, at any time until the Expiration Date, reduce the then
current Warrant Price to any amount deemed appropriate by the Board of Directors of the Company for any period not exceeding twenty consecutive days (as evidenced in a resolution adopted by such Board of Directors), but only upon giving the notices
required by Section 3.5 at least ten days prior to taking such action. 
 (e) Except as herein otherwise expressly
provided, no adjustment in the Warrant Price shall be made by reason of the issuance of shares of Common Stock, or securities convertible into or exchangeable for shares of Common Stock, or securities carrying the right to purchase any of the
foregoing or for any other reason whatsoever. 
 (f) No fractional Warrant Securities shall be issued upon the exercise
of Warrants. If more than one Warrant shall be exercised at one time by the same holder, the number of full Warrant Securities which shall be issuable upon such exercise shall be computed on the basis of the aggregate number of Warrant Securities
purchased pursuant to the Warrants so exercised. Instead of any fractional Warrant Security which would otherwise be issuable upon exercise of any Warrant, the Company shall pay a cash adjustment in respect of such fraction in an amount equal to the
same fraction of the last sales price (or bid price if there were no sales) per Warrant Security, in either case as reported on the New York Stock Exchange Composite Tape on the business day which next precedes the day of exercise or, if the Warrant
Securities are not then listed or admitted to trading on the New York Stock Exchange, on the principal national securities exchange on which the Warrant Securities are listed or admitted to trading or, if not listed or admitted to trading on any
national securities exchange, the average of the closing high bid and low asked prices in the over-the-counter market, as reported by The Nasdaq Stock Market, Inc. (“NASDAQ”), or such other system then in use, or if on any such date the
Warrant Securities are not quoted by any such organization, an amount equal to the same fraction of the average of the closing bid and asked prices as furnished by any New York Stock Exchange firm selected from time to time by the Company for that
purpose at the close of business on the business day which next precedes the day of exercise. 
 (g) Whenever the
Warrant Price then in effect is adjusted as herein provided, the Company shall mail to each holder of the Warrants at such holder’s address as it shall appear on the books of the Company a statement setting forth the adjusted Warrant Price then
and thereafter effective under the provisions hereof, together with the facts, in reasonable detail, upon which such adjustment is based. 
 3.5 Notice To Warrantholders. In case the Company shall (a) effect any dividend or distribution described in Section 3.4(b), (b) effect any Reorganization Event, (c) make any distribution on or in respect of the
Common Stock in connection with the dissolution, liquidation 

 
or winding up of the Company, or (d) reduce the then current Warrant Price pursuant to Section 3.4(d), then the Company shall mail to each holder
of Warrants at such holder’s address as it shall appear on the books of the Warrant Agent, at least ten days prior to the applicable date hereinafter specified, a notice stating (x) the record date for such dividend or distribution, or, if
a record is not to be taken, the date as of which the holders of record of Common Stock that will be entitled to such dividend or distribution are to be determined, (y) the date on which such Reorganization Event, dissolution, liquidation or
winding up is expected to become effective, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such
Reorganization Event, dissolution, liquidation or winding up, or (z) the first date on which the then current Warrant Price shall be reduced pursuant to Section 3.4(d). No failure to mail such notice nor any defect therein or in the
mailing thereof shall affect any such transaction or any adjustment in the Warrant Price required by Section 3.4. 
 3.6 [If The
Warrants Are Subject To Acceleration By The Company, Insert—Acceleration Of Warrants By The Company. 
 (a) At
any time on or after                     , the Company shall have the right to accelerate any or all Warrants at any time by causing
them to expire at the close of business on the day next preceding a specified date (the “Acceleration Date”), if the Market Price (as hereinafter defined) of the Common Stock equals or exceeds
                 percent (            %) of the then effective Warrant Price on any twenty
Trading Days (as hereinafter defined) within a period of thirty consecutive Trading Days ending no more than five Trading Days prior to the date on which the Company gives notice to the Warrant Agent of its election to accelerate the Warrants.

 (b) “Market Price” for each Trading Day shall be, if the Common Stock is listed or admitted for trading on
the New York Stock Exchange, the last reported sale price, regular way (or, if no such price is reported, the average of the reported closing bid and asked prices, regular way) of Common Stock, in either case as reported on the New York Stock
Exchange Composite Tape or, if the Common Stock is not listed or admitted to trading on the New York Stock Exchange, on the principal national securities exchange on which the Common Stock is listed or admitted to trading or, if not listed or
admitted to trading on any national securities exchange, the average of the closing high bid and low asked prices in the over-the-counter market, as reported by NASDAQ, or such other system then in use, or if on any such date the shares of Common
Stock are not quoted by any such organization, the average of the closing bid and asked prices as furnished by any New York Stock Exchange firm selected from time to time by the Company for that purpose. “Trading Day” shall be each Monday
through Friday, other than any day on which securities are not traded in the system or on the exchange that is the principal market for the Common Stock, as determined by the Board of Directors of the Company. 
 (c) In the event of an acceleration of less than all of the Warrants, the Warrant Agent shall select the Warrants to be accelerated
by lot, pro rata or in such other manner as it deems, in its discretion, to be fair and appropriate. 

 (d) Notice of an acceleration specifying the Acceleration Date shall be sent by
mail first class, postage prepaid, to each registered holder of a Warrant Certificate representing a Warrant accelerated at such holder’s address appearing on the books of the Warrant Agent not more than sixty days nor less than thirty days
before the Acceleration Date. Such notice of an acceleration also shall be given no more than twenty days, and no less than ten days, prior to the mailing of notice to registered holders of Warrants pursuant to this Section 3.6, by publication
at least once in a newspaper of general circulation in the City of New York. 
 (e) Any Warrant accelerated may be
exercised until [            ] p.m., [City] time, on the business day next preceding the Acceleration Date. The Warrant Price shall be payable as provided in Section 2.]

 ARTICLE 4 
 EXCHANGE
AND TRANSFER OF WARRANT CERTIFICATES 
 4.1 Exchange And Transfer Of Warrant Certificates. [If Common Stock with Warrants which
are immediately detachable—Upon] [If Common Stock with Warrants which are not immediately detachable—Prior to the Detachable Date, a Warrant Certificate may be exchanged or transferred only together with the Common Stock to which the
Warrant Certificate was initially attached, and only for the purpose of effecting or in conjunction with an exchange or transfer of such Common Stock. Prior to any Detachable Date, each transfer of the Common Stock shall operate also to transfer the
related Warrant Certificates. After the Detachable Date, upon] surrender at the corporate trust office of the Warrant Agent, Warrant Certificates evidencing Warrants may be exchanged for Warrant Certificates in other denominations evidencing such
Warrants or the transfer thereof may be registered in whole or in part; provided that such other Warrant Certificates evidence Warrants for the same aggregate number of Warrant Securities as the Warrant Certificates so surrendered. The Warrant Agent
shall keep, at its corporate trust office, books in which, subject to such reasonable regulations as it may prescribe, it shall register Warrant Certificates and exchanges and transfers of outstanding Warrant Certificates, upon surrender of the
Warrant Certificates to the Warrant Agent at its corporate trust office for exchange or registration of transfer, properly endorsed or accompanied by appropriate instruments of registration of transfer and written instructions for transfer, all in
form satisfactory to the Company and the Warrant Agent. No service charge shall be made for any exchange or registration of transfer of Warrant Certificates, but the Company may require payment of a sum sufficient to cover any stamp or other tax or
other governmental charge that may be imposed in connection with any such exchange or registration of transfer. Whenever any Warrant Certificates are so surrendered for exchange or registration of transfer, an authorized officer of the Warrant Agent
shall manually countersign and deliver to the person or persons entitled thereto a Warrant Certificate or Warrant Certificates duly authorized and executed by the Company, as so requested. The Warrant Agent shall not be required to effect any
exchange or registration of transfer which will result in the issuance of a Warrant Certificate evidencing a Warrant for a fraction of a Warrant Security or a number of Warrants for a whole number of Warrant Securities and a fraction of a Warrant
Security. All Warrant Certificates issued upon any exchange or registration of transfer of Warrant Certificates shall be the valid obligations of the Company, evidencing the same obligations and entitled to the same benefits under this Agreement as
the Warrant Certificate surrendered for such exchange or registration of transfer. 

 4.2 Treatment Of Holders Of Warrant Certificates. [If Common Stock and Warrants are not
immediately detachable—Prior to the Detachable Date, the Company, the Warrant Agent and all other persons may treat the owner of the Common Stock as the owner of the Warrant Certificates initially attached thereto for any purpose and as the
person entitled to exercise the rights represented by the Warrants evidenced by such Warrant Certificates, any notice to the contrary notwithstanding. After the Detachable Date and prior to due presentment of a Warrant Certificate for registration
of transfer, the] [The] Company, the Warrant Agent and all other persons may treat the registered holder of a Warrant Certificate as the absolute owner thereof for any purpose and as the person entitled to exercise the rights represented by the
Warrants evidenced thereby, any notice to the contrary notwithstanding. 
 4.3 Cancellation Of Warrant Certificates. Any Warrant
Certificate surrendered for exchange, registration of transfer or exercise of the Warrants evidenced thereby shall, if surrendered to the Company, be delivered to the Warrant Agent and all Warrant Certificates surrendered or so delivered to the
Warrant Agent shall be promptly canceled by the Warrant Agent and shall not be reissued and, except as expressly permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu thereof. 
 The Warrant Agent shall deliver to the Company from time to time or otherwise dispose of canceled Warrant Certificates in a manner satisfactory to the
Company. 
 ARTICLE 5 
 CONCERNING THE WARRANT AGENT 
 5.1 Warrant Agent. The Company hereby appoints
                     as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject
to the conditions herein set forth, and                      hereby accepts such appointment. The Warrant Agent shall have the powers
and authority granted to and conferred upon it in the Warrant Certificates and hereby and such further powers and authority to act on behalf of the Company as the Company may hereafter grant to or confer upon it. All of the terms and provisions with
respect to such powers and authority contained in the Warrant Certificates are subject to and governed by the terms and provisions hereof. 
 5.2 Conditions Of Warrant Agent’s Obligations. The Warrant Agent accepts its obligations herein set forth upon the terms and conditions hereof, including the following to all of which the Company agrees and to all of which the
rights hereunder of the holders from time to time of the Warrant Certificates shall be subject: 
 (a) Compensation And
Indemnification. The Company agrees promptly to pay the Warrant Agent the compensation to be agreed upon with the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses
(including reasonable counsel fees) incurred without negligence, bad faith or willful misconduct by the Warrant Agent in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent
for, and to hold it harmless against, any loss, liability or expense incurred without negligence, bad faith or willful misconduct on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including
the reasonable costs and expenses of defending against any claim of such liability. 

 (b) Agent For The Company. In acting under this Warrant Agreement and in
connection with the Warrant Certificates, the Warrant Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with any of the holders of Warrant Certificates or beneficial owners
of Warrants. 
 (c) Counsel. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel
for the Company, and the written advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel.

 (d) Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action
taken or omitted by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper
parties. 
 (e) Certain Transactions. The Warrant Agent, and its officers, directors and employees, may become the
owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it or they may engage or be interested in any financial or
other transaction with the Company and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in
this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as trustee under any indenture to which the Company is a party. 
 (f) No Liability For Interest. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for interest on any monies at any time received by it pursuant to any of the provisions of this
Agreement or of the Warrant Certificates. 
 (g) No Liability For Invalidity. The Warrant Agent shall have no liability
with respect to any invalidity of this Agreement or any of the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon). 
 (h) No Responsibility For Representations. The Warrant Agent shall not be responsible for any of the recitals or representations herein or in the Warrant Certificates (except as to the Warrant Agent’s
countersignature thereon), all of which are made solely by the Company. 
 (i) No Implied Obligations. The Warrant
Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates against the Warrant Agent.
The Warrant Agent shall not be under any obligation to take any action hereunder which may tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The Warrant
Agent shall 

 
not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant Certificates authenticated by the Warrant Agent and
delivered by it to the Company pursuant to this Agreement or for the application by the Company of the proceeds of the Warrant Certificates. The Warrant Agent shall have no duty or responsibility in case of any default by the Company in the
performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the receipt of any written demand from a holder of a Warrant Certificate with respect to such default, including, without limiting the
generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or, except as provided in Section 6.2 hereof, to make any demand upon the Company. 
 5.3 Resignation, Removal And Appointment Of Successors. 
 (a) The Company agrees, for the benefit of the holders from time to time of the Warrant Certificates, that there shall at all times
be a Warrant Agent hereunder until all the Warrants have been exercised or are no longer exercisable. 
 (b) The
Warrant Agent may at any time resign as agent by giving written notice to the Company of such intention on its part, specifying the date on which its desired resignation shall become effective; provided that such date shall not be less than three
months after the date on which such notice is given unless the Company otherwise agrees. The Warrant Agent hereunder may be removed at any time by the filing with it of an instrument in writing signed by or on behalf of the Company and specifying
such removal and the intended date when it shall become effective. Such resignation or removal shall take effect upon the appointment by the Company, as hereinafter provided, of a successor Warrant Agent (which shall be a bank or trust company
authorized under the laws of the jurisdiction of its organization to exercise corporate trust powers) and the acceptance of such appointment by such successor Warrant Agent. The obligation of the Company under Section 5.2(a) shall continue to
the extent set forth therein notwithstanding the resignation or removal of the Warrant Agent. 
 (c) In case at any
time the Warrant Agent shall resign, or shall be removed, or shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter constituted, or
under any other applicable Federal or state bankruptcy, insolvency or similar law or shall consent to the appointment of or taking possession by a receiver, custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the
Warrant Agent or its property or affairs, or shall make an assignment for the benefit of creditors, or shall admit in writing its inability to pay its debts generally as they become due, or shall take corporate action in furtherance of any such
action, or a decree or order for relief by a court having jurisdiction in the premises shall have been entered in respect of the Warrant Agent in an involuntary case under the Federal bankruptcy laws, as now or hereafter constituted, or any other
applicable Federal or state bankruptcy, insolvency or similar law, or a decree or order by a court having jurisdiction in the premises shall have been entered for the appointment of a receiver, custodian, liquidator, assignee, trustee, sequestrator
(or similar official) of the Warrant Agent or of its property or affairs, or any public officer shall take charge or control of the Warrant Agent or of its property or affairs for the purpose of rehabilitation, conservation, winding up or
liquidation, a successor Warrant Agent, qualified as aforesaid, shall be appointed by the Company by an instrument in writing, filed with the successor Warrant Agent. Upon the appointment as aforesaid of a successor Warrant Agent and acceptance by
the successor Warrant Agent of such appointment, the Warrant Agent shall cease to be Warrant Agent hereunder. 

 (d) Any successor Warrant Agent appointed hereunder shall execute, acknowledge and
deliver to its predecessor and to the Company an instrument accepting such appointment hereunder, and thereupon such successor Warrant Agent, without any further act, deed or conveyance, shall become vested with all the authority, rights, powers,
trusts, immunities, duties and obligations of such predecessor with like effect as if originally named as Warrant Agent hereunder, and such predecessor, upon payment of its charges and disbursements then unpaid, shall thereupon become obligated to
transfer, deliver and pay over, and such successor Warrant Agent shall be entitled to receive, all monies, securities and other property on deposit with or held by such predecessor, as Warrant Agent hereunder. 
 (e) Any corporation into which the Warrant Agent hereunder may be merged or converted or any corporation with which the Warrant
Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party, or any corporation to which the Warrant Agent shall sell or otherwise transfer all or substantially all
the assets and business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the
parties hereto. 
 ARTICLE 6 
 MISCELLANEOUS 
 6.1 Amendment. This Agreement may be amended by the parties hereto, without the consent of the holder
of any Warrant Certificate, for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein, or making any other provisions with respect to matters or questions arising under this Agreement
as the Company and the Warrant Agent may deem necessary or desirable; provided that such action shall not materially adversely affect the interests of the holders of the Warrant Certificates. 
 6.2 Notices And Demands To The Company And Warrant Agent. If the Warrant Agent shall receive any notice or demand addressed to the Company by the
holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent shall promptly forward such notice or demand to the Company. 
 6.3 Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to
                    , Attention:
                     and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to
Kosan Biosciences Incorporated, 3832 Bay Center Place, Hayward, CA 94545, Attention: Corporate Secretary (or such other address as shall be specified in writing by the Warrant Agent or by the Company). 
 6.4 Governing Law. This Agreement and each Warrant Certificate issued hereunder shall be governed by and construed in accordance with the laws of
the State of New York. 

 6.5 Delivery Of Prospectus. The Company shall furnish to the Warrant Agent sufficient copies of a
prospectus meeting the requirements of the Securities Act of 1933, as amended, relating to the Warrant Securities deliverable upon exercise of the Warrants (the “Prospectus”), and the Warrant Agent agrees that upon the exercise of any
Warrant, the Warrant Agent will deliver to the holder of the Warrant Certificate evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Securities issued upon such exercise, a Prospectus. 
 The Warrant Agent shall not, by reason of any such delivery, assume any responsibility for the accuracy or adequacy of such Prospectus. 
 6.6 Obtaining Of Governmental Approvals. The Company will from time to time take all action which may be necessary to obtain and keep effective
any and all permits, consents and approvals of governmental agencies and authorities and securities act filings under United States Federal and state laws (including without limitation a registration statement in respect of the Warrants and Warrant
Securities under the Securities Act of 1933, as amended), which may be or become requisite in connection with the issuance, sale, transfer, and delivery of the Warrant Securities issued upon exercise of the Warrants, the issuance, sale, transfer and
delivery of the Warrants or upon the expiration of the period during which the Warrants are exercisable. 
 6.7 Persons Having Rights
Under Warrant Agreement. Nothing in this Agreement shall give to any person other than the Company, the Warrant Agent and the holders of the Warrant Certificates any right, remedy or claim under or by reason of this Agreement. 
 6.8 Headings. The descriptive headings of the several Articles and Sections of this Agreement are inserted for convenience only and shall not
control or affect the meaning or construction of any of the provisions hereof. 
 6.9 Counterparts. This Agreement may be executed in
any number of counterparts, each of which as so executed shall be deemed to be an original, but such counterparts shall together constitute but one and the same instrument. 
 6.10 Inspection Of Agreement. A copy of this Agreement shall be available at all reasonable times at the principal corporate trust office of the
Warrant Agent for inspection by the holder of any Warrant Certificate. The Warrant Agent may require such holder to submit his Warrant Certificate for inspection by it. 

 IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed, all as of the day and year first above written. 
  

			
	KOSAN BIOSCIENCES INCORPORATED
		
	By	 	 
		
	Its	 	 

  

	
	Attest:
	
	  
	
	  

  

			
	Warrant Agent
		
	By	 	 
		
	Its	 	 

  

	
	Attest:
	
	  
	
	  

 [SIGNATURE PAGE TO COMMON STOCK WARRANT AGREEMENT] 

 EXHIBIT A 
 FORM OF WARRANT CERTIFICATE 
 [FACE OF WARRANT CERTIFICATE] 
  

			
	[Form if Warrants are attached to Common Stock and are not immediately detachable.]	  	[Prior to                     , this Warrant Certificate cannot be transferred or
exchanged unless attached to Common Stock.]
		
	[Form of Legend if Warrants are not immediately exercisable.]	  	[Prior to                     , Warrants evidenced by this Warrant
Certificate cannot be exercised.]

 EXERCISABLE ONLY IF COUNTERSIGNED BY THE WARRANT AGENT AS PROVIDED HEREIN 
 VOID AFTER [            ] P.M., [CITY] TIME, ON
                    , 

 KOSAN BIOSCIENCES INCORPORATED 
 WARRANT CERTIFICATE REPRESENTING 
 WARRANTS TO PURCHASE 
 COMMON STOCK, PAR VALUE $0.001 PER SHARE 
  

			
	 No.                    
	  	Warrants

 This certifies that
                     or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling
such owner [if Warrants are attached to Common Stock and are not immediately detachable—, subject to the registered owner qualifying as a “Holder” of this Warrant Certificate, as hereinafter defined),] to purchase, at any time [after
[            ] p.m., [City] time, on              and] on or before
[            ] p.m., [City] time, on                     ,
             shares of Common Stock, par value $0.001 per share (the “Warrant Securities”), of KOSAN BIOSCIENCES INCORPORATED (the “Company”) on the
following basis: during the period from                     , through and including
                    , the exercise price per Warrant Security will be
$            , subject to adjustment as provided in the Warrant Agreement (as hereinafter defined) (the “Warrant Price”). The Holder may exercise the Warrants
evidenced hereby by providing certain information set forth on the back hereof and by paying in full, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank
wire transfer in immediately available funds], the Warrant Price for each Warrant Security with respect to which this Warrant is exercised to the Warrant Agent (as hereinafter defined) and by surrendering this Warrant Certificate, with the purchase
form on the back hereof duly executed, at the corporate trust office of [name of Warrant Agent], or its successor as warrant agent (the “Warrant Agent”), which is, on the date hereof, at the address specified on the reverse hereof, and
upon compliance with and subject to the conditions set forth herein and in the Warrant Agreement (as hereinafter defined). 
 The term
“Holder” as used herein shall mean [if Warrants are attached to Common Stock and are not immediately detachable—prior to
                    ,              (the “Detachable
Date”), the registered owner of the Company’s Common Stock to which this Warrant Certificate was initially attached, and after such Detachable Date,] the person in whose name at the time this Warrant Certificate shall be registered upon
the books to be maintained by the Warrant Agent for that purpose pursuant to Section 4 of the Warrant Agreement. 
 The Warrants
evidenced by this Warrant Certificate may be exercised to purchase a whole number of Warrant Securities in registered form. Upon any exercise of fewer than all of the Warrants evidenced by this Warrant Certificate, there shall be issued to the
Holder hereof a new Warrant Certificate evidencing Warrants for the number of Warrant Securities remaining unexercised. 
 This Warrant
Certificate is issued under and in accordance with the Warrant Agreement dated as of                     ,
             (the “Warrant Agreement”), between the Company and the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to
all of which terms and provisions the Holder of this Warrant Certificate consents by acceptance hereof. Copies of the Warrant Agreement are on file at the above-mentioned office of the Warrant Agent. 
  

 [If Warrants are attached to Common Stock and are not immediately detachable - Prior to the Detachable
Date, this Warrant Certificate may be exchanged or transferred only together with the [Title of Common Stock] (the “Common Stock”) to which this Warrant Certificate was initially attached, and only for the purpose of effecting or in
conjunction with, an exchange or transfer of such Common Stock. Additionally, on or prior to the Detachable Date, each transfer of such Common Stock on the register of the Common Stock shall operate also to transfer this Warrant Certificate. After
such date, transfer of this] [If Warrants are attached to Common Stock and are immediately detachable - Transfer of this] Warrant Certificate may be registered when this Warrant Certificate is surrendered at the corporate trust office of the Warrant
Agent by the registered owner or such owner’s assigns, in the manner and subject to the limitations provided in the Warrant Agreement. 
 [If Common Stock with Warrants which are not immediately detachable - Except as provided in the immediately preceding paragraph, after] [If Common Stock with Warrants which are immediately detachable or Warrants alone - After]
countersignature by the Warrant Agent and prior to the expiration of this Warrant Certificate, this Warrant Certificate may be exchanged at the corporate trust office of the Warrant Agent for Warrant Certificates representing Warrants for the same
aggregate number of Warrant Securities. 
 This Warrant Certificate shall not entitle the Holder hereof to any of the rights of a holder of
the Warrant Securities, including, without limitation, the right to receive payments of dividends or distributions, if any, on the Warrant Securities (except to the extent set forth in the Warrant Agreement) or to exercise any voting rights.

 Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof, which further provisions
shall for all purposes have the same effect as if set forth at this place. 
 This Warrant Certificate shall not be valid or obligatory for
any purpose until countersigned by the Warrant Agent. 

 IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed in its name and on its behalf by the facsimile signatures of its duly authorized officers. 
  

			
	Dated:	 	 

  

			
	KOSAN BIOSCIENCES INCORPORATED
		
	By	 	 
		
	Its	 	 

  

			
	Attest:	 	
		
	 	 	 

  

			
	Countersigned:
		
	 	 	 
		 	As Warrant Agent
		
	By	 	 
		 	Authorized Signature

 [REVERSE OF WARRANT CERTIFICATE] 
 (Instructions for Exercise of Warrant) 
 To exercise any Warrants evidenced
hereby for Warrant Securities (as hereinafter defined), the Holder must pay, in lawful money of the United States of America, [in cash or by certified check or official bank check in [New York Clearing House funds] [by bank wire transfer in
immediately available funds], the Warrant Price in full for Warrants exercised, to [Warrant Agent] [address of Warrant Agent], Attn:
                    , which payment must specify the name of the Holder and the number of Warrants exercised by such Holder. In addition, the
Holder must complete the information required below and present this Warrant Certificate in person or by mail (certified or registered mail is recommended) to the Warrant Agent at the appropriate address set forth above. This Warrant Certificate,
completed and duly executed, must be received by the Warrant Agent within five business days of the payment. 
 (To be executed upon exercise
of Warrants) 
 The undersigned hereby irrevocably elects to exercise
                     Warrants, evidenced by this Warrant Certificate, to purchase
                     shares of the Common Stock, par value $0.001 per share (the “Warrant Securities”), of KOSAN BIOSCIENCES
INCORPORATED and represents that he has tendered payment for such Warrant Securities, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in
immediately available funds], to the order of KOSAN BIOSCIENCES INCORPORATED, c/o [insert name and address of Warrant Agent], in the amount of $             in accordance with
the terms hereof. The undersigned requests that said Warrant Securities be in fully registered form in the authorized denominations, registered in such names and delivered all as specified in accordance with the instructions set forth below.

 If the number of Warrants exercised is less than all of the Warrants evidenced hereby, the undersigned requests that a new Warrant
Certificate evidencing the Warrants for the number of Warrant Securities remaining unexercised be issued and delivered to the undersigned unless otherwise specified in the instructions below. 
  

									
					
	Dated	 	 	 		 	Name	 	 
		 		 		 		 	Please Print
					
	Address:	 	 	 		 		 	
				
	 	 		 		 	
				
	 	 		 		 	
	(Insert Social Security or Other Identifying Number of Holder)	 		 		 	

  

			
		
	Signature Guaranteed	 	 
		 	Signature

 (Signature must conform in all respects to name of holder as specified on the face of this Warrant Certificate and must
bear a signature guarantee by a bank, trust company or member broker of the New York, Midwest or Pacific Stock Exchange). 
 This Warrant may be exercised at
the following addresses: 
  

			
		
	By hand at	 	 
		
	 	 	 
		
	 	 	 
		
	By mail at	 	 
		
	 	 	 
		
	 	 	 

 [Instructions as to form and delivery of Warrant Securities and, if applicable, Warrant Certificates evidencing
Warrants for the number of Warrant Securities remaining unexercised—complete as appropriate.] 

 ASSIGNMENT 
 [Form of assignment to be executed if Warrant Holder desires to transfer Warrant] 
 FOR VALUE RECEIVED,
                     hereby sells, assigns and transfers unto: 
  

									
	 	 	 	 		 	
				
	 	 	 	 		 	
				
	 	 	 	 		 	 
	(Please print name and address including zip code)	 		 	Please print Social Security or other identifying number

 the right represented by the within Warrant to purchase
                     shares of [Title of Warrant Securities] of KOSAN BIOSCIENCES INCORPORATED to which the within Warrant relates and
appoints                      attorney to transfer such right on the books of the Warrant Agent with full power of substitution in the
premises. 
  

									
	Dated	 	 	 		 		 	 
		 		 		 		 	Signature

 (Signature must conform in all respects to name of holder as specified on the face of the Warrant)

  

	
	Signature GuaranteedForm of Executive Severance Agreement

 Exhibit 10.1 
 EXECUTIVE SEVERANCE AGREEMENT 
  

					
	PARTIES:	  	Planar Systems, Inc.	  	(“Company”)
		  	1195 NW Compton Drive	  	
		  	Beaverton, Oregon 97006	  	
			
		  	[Executive’s Name]	  	(“Executive”)
		  	[Executive’s Address]	  	
			
	DATE:	  	June 25, 2007	  	(“Effective Date”)

 RECITAL: 
 The Board of Directors of the Company considers the maintenance of sound and vital management to be essential to protecting and enhancing the best interests of the Company and its shareholders. In this connection, and
in order to induce Executive to remain employed by the Company in the face of longer-term uncertainties including a potential change of control of the Company and the potential impact of such uncertainties on Executive’s position with the
Company, this Agreement, which has been approved by the Company’s Board of Directors, sets forth the severance benefits that the Company will provide to Executive in the event Executive’s employment with the Company is terminated under the
circumstances described in this Agreement. 
 AGREEMENT: 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 ARTICLE 1 
 DEFINITIONS 
 1.1 “Board” shall mean the Board of Directors of the Company. 
 1.2 “Cause” shall mean any of the following: 
 (i) Executive’s fraud or misrepresentation; 
 (ii) Executive’s theft or embezzlement of Company
assets; 
 (iii) Executive’s commission of a felony involving moral turpitude; 
 (iv) Executive’s continued failure to satisfactorily perform the duties reasonably assigned to Executive (including observing all applicable Company
employment polices), for a period of thirty (30) days after a written demand for such satisfactory performance that specifically and with reasonable detail identifies the manner in which it is alleged that Executive has not satisfactorily
performed such duties; or 
  

 Page 1 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 (v) Executive’s material breach of this Agreement that, if curable, has not been cured within thirty
(30) days after written notice to Executive of such breach. 
 1.3 “Change in Control” shall mean the occurrence
of any of the following events: 
 (i) The approval by the Company’s shareholders of a merger, statutory plan of exchange or
consolidation to which the Company is a party, if the individuals and entities who were shareholders of the Company immediately prior to the effective date of such merger, plan of exchange or consolidation would have beneficial ownership (as defined
in Rule 13d-3 under the Securities Exchange Act of 1934) of less than fifty percent (50%) of the total combined voting power for election of directors of the surviving corporation immediately following the effective date of such merger or
consolidation; 
 (ii) The acquisition (other than directly from the Company) by any person or entity, or group of associated persons or
entities acting in concert, of direct or indirect beneficial ownership (as defined in Rule 13d-3 under the Securities Exchange Act of 1934) of securities of the Company representing twenty-five percent (25%) or more of the total combined voting
power of the Company’s then issued and outstanding securities; 
 (iii) The approval by the Company’s shareholders of the sale,
lease, exchange or other transfer (in one or a series of related transactions) of all or substantially all of the assets of the Company to any person or entity that is not a wholly owned subsidiary of the Company; 
 (iv) The approval by the Company’s shareholders of any plan or proposal for the liquidation or dissolution of the Company; or 
 (v) A change in the Board with the result that the members of the Board on the Effective Date hereof (the “Incumbent Directors”) no longer
constitute a majority of such Board, provided that any person becoming a director whose election or nomination for election was supported by a majority of the Incumbent Directors shall be considered an Incumbent Director for purposes hereof.

 1.4 “Company” shall mean Planar Systems, Inc. and any successor in interest by way of consolidation, operation of
law, merger or otherwise. 
 1.5 “Disability” shall mean the inability of Executive to perform, with reasonable
accommodation, if necessary, any essential functions of his or her position under this Agreement because of physical or mental incapacity for a period of one hundred twenty (120) days in the aggregate during any twelve (12)-month period.

 1.6 “Good Reason” shall mean that any one or more of the following events occurs or condition exists, without
Executive’s express written consent; provided, however, that Executive shall have given written notice to Company of such event or condition alleged to comprise “Good Reason” and thirty (30) days shall have passed with no cure
having been made: 
 (i) A reduction by the Company in Executive’s Base Salary or any failure to pay Executive, when due, any
compensation or benefits to which Executive is entitled; 
  

 Page 2 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 (ii) A significant reduction by the Company in the total benefits available to Executive under cash
incentive, stock incentive or other employee benefit plans after a Change of Control as compared to the total package of such benefits as in effect prior to the Change of Control; 
 (iii) A requirement by the Company that Executive be based anywhere other than within 25 miles of Beaverton, Oregon; 
 (iv) The Company’s failure to obtain an agreement, reasonably satisfactory to Executive, from any successor or assign of the Company to assume and
agree to perform the Company’s obligations under this Agreement; 
 (v) Reassignment of Executive to a different title, job or
responsibilities that result in a significant decrease in the level of responsibility of Executive after a Change of Control as compared with Executive’s level of responsibility for the Company’s operations prior to the Change of Control;
provided that Good Reason shall not exist if Executive continues to have substantially the same or greater responsibilities for the former Company operations after the Change of Control as Executive had prior to the Change of Control even if the
former Company operations are a subsidiary or division of the surviving company; or 
 (vi) Any material breach of this Agreement by the
Company. 
 ARTICLE 2 
 EMPLOYMENT 
 2.1 Employment. Executive is currently employed by the Company as
                    . The Company and Executive acknowledge that either party may terminate this employment relationship at any time for any
or no reason, subject to the obligation of the Company to provide the severance benefits set forth in this Agreement in accordance with the terms hereof. 
 2.2 Duties. Executive shall devote his full-time and best efforts to the Company and to fulfilling the duties of his position. Executive shall comply with the Company’s policies and procedures to the
extent that they are not inconsistent with this Agreement, in which case the provisions of this Agreement shall prevail. 
 2.3 Term.
The term of this Agreement (the “Term”) shall begin on the Effective Date hereof and remain in effect until the earlier of: (i) termination pursuant to Article 4 of this Agreement or (ii) October 1, 2008; provided, however, that
commencing on October 1, 2008 and each anniversary thereafter, the Term shall automatically be extended for one additional year unless at least 90 days prior to such anniversary, Executive or the Company shall have given written notice to the
other that the Term shall not be extended; provided further, however, that if a Change in Control shall have occurred, the Agreement shall remain in effect until the earlier of: (i) termination pursuant to Article 4 of this Agreement or
(ii) twenty-four (24) months following the Change in Control. 
  

 Page 3 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 ARTICLE 3 
 TERMINATION 
 3.1 Termination. This Agreement may be terminated by either party by providing
the other party with written notice that indicates the specific termination provision in this Agreement relied upon and sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so
indicated (a “Notice of Termination”). For purposes of Section 3, if Executive is assigned additional or different titles, tasks or responsibilities from those currently held or assigned, consistent with Executive’s general areas
of professional expertise and with no decrease in annual base compensation, whether with the Company or any subsidiary of the Company, such circumstances shall not constitute termination of Executive’s Employment or this Agreement. 

3.2 Executive’s Resignation. Executive may terminate this Agreement and Executive’s employment upon thirty (30) days’
advance Notice of Termination. Upon termination by Executive pursuant to this Section 3.2, Company shall pay Executive: 
 (i) Base
Salary and Annual Bonus, if any, earned and payable through the effective date of such termination, together with any other compensation or benefits that have been earned or become payable as of the date of termination but have not yet been paid to
Executive; 
 (ii) Pay-out of accrued paid time off in accordance with Company policies; and 
 (iii) Reimbursement of business expenses incurred through the effective date of such termination (items 3.2 (i), (ii) and (iii) shall be
referred to collectively as the “Accrued Obligations”). 
 3.3 Termination by the Company for Cause. Company may terminate
this Agreement and Executive’s employment immediately for Cause upon Notice of Termination. Upon termination by Company for Cause pursuant to this Section 3.3, Executive shall be paid the Accrued Obligations. 
 3.4 Termination by the Company Without Cause. The Company may terminate this Agreement and Executive’s employment without Cause upon thirty
(30) days’ advance Notice of Termination; provided, however, that the Company may in its sole discretion make termination of the Agreement and Executive’s employment effective immediately upon Notice of Termination, in which case, in
addition to the payments otherwise required by this Section 3.4, Executive shall be paid his Base Salary through a notice period of thirty (30) days. The Company’s failure to at any time renew the term of this Agreement under
Section 2.3 shall be deemed a termination of this Agreement and Executive’s employment without Cause. If the Company terminates Executive’s employment without Cause pursuant to this Section 3.4, Executive shall be entitled to
receive the Accrued Obligations and, subject to satisfaction of the Release of Claims requirement specified in Section 3.13 below, shall be entitled to the benefits specified under either subparagraph (i) or subparagraph (ii) below:

  

 Page 4 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 (i) No Change in Control Has Occurred. If there has been no Change in Control within twenty-four
(24) months prior to Executive’s termination pursuant to this Section 3.4 or within ninety (90) days following Executive’s termination pursuant to this Section 3.4: 
 A. For a period of twelve (12) months following the effective date of Executive’s termination, the Company shall continue to pay
Executive his/ her Base Salary at the rate in effect just prior to the time a Notice of Termination is delivered, payable according to the Company’s normal payroll practices; 
 B. If Executive elects to continue his Company-provided group health benefits at the level in effect as of the date of termination under
the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), the Company shall pay the premiums for Executive’s COBRA continuation coverage (for Executive and Executive’s dependents, if applicable) for a period of up to
eighteen (18) months; and 
 C. Company shall make available to Executive for a period of twelve (12) months after
termination, outplacement services provided that (i) the outplacement program and the provider of which shall be selected by Company and (ii) the outplacement services are performed within such 12-month period. 
 (ii) Change in Control Has Occurred. If Executive’s termination pursuant to this Section 3.4 occurs within twenty-four (24) months
following a Change in Control or if Executive is terminated pursuant to this Section 3.4 and a Change in Control occurs within ninety (90) days following Executive’s termination: 
 A. Each month for a period of twelve (12) months following the effective date of Executive’s termination, the Company shall
continue to pay Executive: (i) Executive’s Base Salary at the rate in effect just prior to the time a Notice of Termination is delivered plus (ii) one-twelfth of 100% of Executive’s targeted annual bonus (or other variable
compensation program) for the year in which Notice of termination is delivered. Payments shall be made according to the Company’s normal payroll practices; 
 B. If Executive elects to continue his Company-provided group health benefits at the level in effect as of the date of termination under
COBRA, the Company shall pay the premiums for Executive’s COBRA continuation coverage (for Executive and Executive’s dependents, if applicable) for a period of up to eighteen (18) months; 
 C. Company shall make available to Executive for a period of twelve (12) months after termination, outplacement services provided
that (i) the outplacement program and the provider of which shall be selected by Company and (ii) the outplacement services are performed within such 12-month period; and 
 D. All outstanding options to purchase stock of the Company (or any successor) held by Executive that are subject to time-based vesting
and all grants of restricted Company stock held by Executive that are subject to time-based vesting shall become fully vested as of the effective date of Executive’s termination. In the event that 

  

 Page 5 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 
there is a Change in Control within 90 days after Executive’s employment was terminated by the Company pursuant to this Section 3.4 and stock
options or stock grants were terminated or forfeited to the Company upon Executive’s employment termination pursuant to their terms (because the Change in Control had not occurred at the time of employment termination), the Company shall pay
Executive the value of the terminated or forfeited options or shares based upon the per-share proceeds payable to the shareholders of the Company upon such Change of Control. 
 3.5 Termination in the Event of Death. This Agreement and Executive’s employment shall terminate automatically upon Executive’s death.
Upon termination pursuant to this Section 3.5, Company shall: 
 (i) Pay the Accrued Obligations to Executive’s spouse or as
otherwise required by state law; 
 (ii) If Executive’s qualified beneficiaries elect to continue Company group health benefits under
COBRA, the Company shall pay the premiums for Executive’s qualified beneficiaries’ COBRA continuation coverage for a period of up to eighteen (18) months; 
 (iii) All outstanding restricted stock grants held by Executive upon Executive’s death that are subject to time-based vesting that would, by their terms, vest within twelve (12) months after Executive’s
death, shall become fully vested as of the date of Executive’s death; 
 (iv) All outstanding options to purchase Company stock held by
Executive upon Executive’s death that are subject to time-based vesting that would, by their terms, vest within twelve (12) months after Executive’s death, shall become fully vested as of the date of Executive’s death; and

 (v) Executive’s estate or a person who acquired the right to exercise Executive’s Company stock options by bequest or
inheritance or otherwise by reason of the death of Executive, shall have until the earlier of (a) the option expiration date or (b) the date that is twelve (12) months after the date of Executive’s death to exercise Company stock
options that are vested as of the date of Executive’s death, including options that vest pursuant to this Section 3.5. 
 3.6
Termination in the Event of Disability. Company may terminate this Agreement and Executive’s employment in the event of Executive’s Disability. Executive shall cooperate with the Company to provide information and submit to such
examinations as the Company may find necessary to make a determination regarding Executive’s Disability. Upon termination pursuant to this Section 3.6, Executive shall be entitled to receive the Accrued Obligations and, subject to
satisfaction of the Release of Claims requirement specified in Section 3.13 below: 
 (i) All outstanding restricted stock grants held by
Executive at the effective date of Executive’s termination that are subject to time-based vesting and that would, by their terms, vest within twelve (12) months after the effective date of Executive’s termination shall become fully
vested as of the effective date of Executive’s termination; 
  

 Page 6 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 (ii) all outstanding options to purchase Company stock held by Executive at the effective date of
Executive’s termination that are subject to time-based vesting and that would, by their terms, vest within twelve (12) months after the effective date of Executive’s termination shall become fully vested as of the effective date of
Executive’s termination; and 
 (iii) stock options that are vested as of the effective date of Executive’s termination including
options that vest pursuant to this Section 3.6 shall be exercised before the earlier of (a) the option expiration date or (b) the date that is twelve (12) months after the effective date of Executive’s termination.

 3.7 Termination by Executive for Good Reason Following Change in Control. Within twenty-four (24) months following a Change in
Control or within ninety (90) days prior to a Change in Control, Executive may terminate this Agreement and his employment with Company for Good Reason upon Notice of Termination. Upon Executive’s termination for Good Reason pursuant to
this Section 3.7, Executive shall be entitled to receive the Accrued Obligations and, subject to satisfaction of the Release of Claims requirement specified in Section 3.13 below: 
 (i) Each month for a period of twelve (12) months following the effective date of Executive’s termination, the Company shall continue to pay
Executive: (i) Executive’s Base Salary at the rate in effect just prior to the time a Notice of Termination is delivered plus (ii) one-twelfth of 100% of Executive’s targeted annual bonus (or other variable compensation program)
for the year in which Notice of termination is delivered. Payments shall be made according to the Company’s normal payroll practices; 
 (ii) If Executive elects to continue his Company-provided group health benefits at the level in effect as of the date of termination under COBRA, the Company shall pay the premiums for Executive’s COBRA continuation coverage (for
himself and his dependents, if applicable) for a period of up to eighteen (18) months; 
 (iii) Company shall make available to
Executive for a period of twelve (12) months after termination, outplacement services provided that (i) the outplacement program and the provider of which shall be selected by Company and (ii) the outplacement services are performed
within such 12-month period; and 
 (iv) All outstanding options to purchase stock of the Company (or any successor) held by Executive as of
the effective date of Executive’s termination that are subject to time-based vesting, and all grants of restricted Company stock held by Executive as of the effective date of Executive’s termination that are subject to time-based vesting,
shall become fully vested as of the effective date of Executive’s termination. In the event that there was a Change in Control within 90 days after Executive terminates employment pursuant to this Section 3.7 and stock options or stock
grants were terminated or forfeited to the Company upon Executive’s employment termination pursuant to their terms (because the Change in Control had not occurred at the time of employment termination), the Company shall pay Executive the value
of the terminated or forfeited options or shares based on the per-share proceeds payable to the shareholders of the Company upon such Change of Control. 
  

 Page 7 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 3.8 Options and Restricted Stock. Any options or restricted stock awarded to Executive shall, in
the event of a termination of Executive’s employment and except as otherwise provided in this Article 3, be governed by the provisions of the applicable award agreement; provided that the accelerated vesting and stock option exercise
provisions of this Article 3 shall, if triggered, control in the event of any inconsistency with any such agreement and the stock option or stock restriction plan and all related agreements. Notwithstanding anything herein to the contrary, upon
the occurrence of a Change of Control all unvested restricted shares of Company stock held by Executive subject to performance-based vesting provisions shall hereby be amended to eliminate such performance-based vesting provisions and substitute
time-based vesting provisions on the basis that such unvested shares shall vest ratably over the period commencing on the date of the Change of Control and ending on the last day of the measuring period to be used for determining whether the
performance criteria would have been satisfied. 
 3.9 No Obligation of Executive to Mitigate. The amount of any payment provided for
in this Article 3 shall not be reduced, offset or subject to recovery by the Company by reason of any compensation earned by Executive as the result of employment by another employer after the date of termination, or otherwise. 
 3.10 Entire Termination Payment. The compensation provided for in this Article 3 shall constitute Executive’s sole remedy for
termination or breach of this Agreement. Under no circumstances shall Executive be entitled to severance pay and related benefits under more than one section of this Agreement. 
 3.11 Resignation from the Board. Upon termination of Executive’s employment with the Company for any reason, Executive shall offer his
resignation as an officer or director of the Company and any subsidiary or affiliate of the Company in which he holds such positions. 
 3.12 Section 280G Provision. 
 (i) Notwithstanding anything contained in this Agreement to the contrary, to the extent
that any payment, distribution, transfer, benefit or other event with respect to the Company or a successor or direct or indirect subsidiary or affiliate of the Company (or any successor or affiliate of any of them, and including any benefit plan of
any of them), arising in connection with an event described in Section 280G(b)(2)(A)(i) of the Internal Revenue Code (the “Code”), occurring after the Effective Date, to or for the benefit of Executive or Executive’s dependents,
heirs or beneficiaries (whether such payment, distribution, transfer, benefit or other event occurs pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional payments required under this Article 3)
(each a “Payment” and collectively the “Payments”) is, was or will be subject to the excise tax imposed by Section 4999 of the Code and any successor provision or any comparable provision of state or local income tax law
(collectively “Section 4999”), then Executive may elect to have the Company reduce the Payments (but not below zero) so that the maximum amount of the Payments shall be One Dollar ($1) less than the amount that would cause
the Payments to be subject to the excise tax imposed by Section 4999. If a reduction of Payments is elected by Executive pursuant to the foregoing, then unless Executive shall have given prior written notice to the Company to effectuate a
reduction in the Payments in a different manner, the Company shall reduce or 

  

 Page 8 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 
eliminate the Payments by first reducing or eliminating any cash severance benefits, then reducing or eliminating any accelerated vesting of stock options,
then reducing or eliminating any accelerated vesting of restricted stock, then reducing or eliminating any other remaining Payments. The preceding provisions of this Section 3.12 shall take precedence over the provisions of any other plan,
arrangement or agreement governing Executive’s rights and entitlements to any benefits or compensation. 
 (ii) The determination that a
Payment is subject to an excise tax (and the amount of such tax) or a determination of the amount by which the Payments must be reduced to reduce the amount of Payments to One Dollar ($1) less than the amount that would cause the Payments to be
subject to the excise tax imposed by Section 4999 (the “Reduction Amount”) shall be made in writing by a certified public accounting firm selected by the Company. 
 3.13 Release of Claims Requirement. As a condition of receiving severance pay and benefits pursuant to this Article 3, at the time of
termination and within twenty-one (21) days of Company delivering the release of claims to Executive, Executive shall enter into and not revoke a release of all claims against the Company substantially in the form attached hereto as
Exhibit A updated to reflect such changes in the law as Company may deem necessary or advisable. 
 3.14
Non-disparagement. Neither party will make any malicious, disparaging or false remarks about the other or their respective officers, directors, employees, heirs or assigns. The parties further agree to refrain from making any
negative statements regarding the other to any third parties or any statements which could be construed as having or causing a diminishing effect on the other’s reputation, goodwill or business. 
 ARTICLE 4 
 CONFIDENTIALITY/PROPRIETARY RIGHTS 
 Executive acknowledges that the Confidentiality and Proprietary Rights Agreement
Executive entered into with Planar dated                     , a copy of which is attached hereto as Exhibit B, remains in full
force and effect. 
 ARTICLE 5 
 GENERAL PROVISIONS 
 5.1 Notices. All notices, requests and demands given to or made pursuant hereto shall, except as
otherwise specified herein, be in writing and shall be deemed to have been duly given to any party when delivered personally (by courier service or otherwise), when delivered by facsimile and confirmed, or three (3) days after being mailed by
first-class mail, postage prepaid and return receipt requested in each case to the applicable address as set forth at the beginning of this Agreement. Either party may change its address, by notice to the other party given in the manner set forth in
this Section 5.1. 
 5.2 Caption. The various headings or captions in this Agreement are for convenience only and shall not
affect the meaning or interpretation of this Agreement. 
 5.3 Governing Law/Forum. The validity, construction and performance of this
Agreement shall be governed by the laws of the state of Oregon. The exclusive forum for any disputes arising under this Agreement that are not subject to arbitration shall be the appropriate state or federal court located in Portland, Oregon.

  

 Page 9 – EXECUTIVE SEVERANCE AGREEMENT 
     [Executive’s Name] 

 5.4 Mediation. In case of any dispute arising under this Agreement that cannot be settled within
60 days after either party has notified the other party of the existence of a dispute by reasonable discussion, the parties agree that, prior to commencing any arbitration proceeding as contemplated by Section 5.5 below, they will first engage
the services of a professional mediator agreed upon by the parties and attempt in good faith to resolve the dispute through confidential nonbinding mediation. Each party shall bear one-half (1/2) of the mediator’s fees and expenses and
shall pay all of its own attorneys’ fees and expenses related to the mediation. 
 5.5 Arbitration. Any dispute concerning the
interpretation, construction, breach or enforcement of this Agreement or arising in any way from Executive’s employment with the Company or termination of employment shall be submitted to final and binding arbitration. The arbitration is to be
conducted before a single arbitrator in Portland, Oregon. The arbitration shall be conducted pursuant to the rules of the American Arbitration Association. Executive and the Company agree that, except for the Company’s right to ask a court for
injunctive relief to enforce the Confidentiality and Proprietary Rights Agreement, the procedures outlined in Section 5.4 and this Section 5.5 are the exclusive method of dispute resolution. 
 5.6 Attorneys’ Fees. If any action at law or in equity is taken to enforce or interpret the terms of this Agreement, the prevailing party
shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled, including fees and expenses on appeal. In any dispute resolved through arbitration under
Section 5.5, the arbitrator shall have sole discretion to determine whether or not fees, costs or disbursements shall be awarded to a party. 
 5.7 Construction. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be prohibited by or invalid
under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity without invalidating the remainder of such provision or the remaining provisions of this Agreement. The severance benefits provided herein
are in lieu of any other severance plan or provision offered by the Company. 
 5.8 Waivers. No failure on the part of either party to
exercise, and no delay in exercising, any right or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right or remedy hereunder preclude any other or further exercise thereof or the exercise of any
other right or remedy granted hereby or by any related document or by law. 
 5.9 Successors and Assigns. This Agreement shall be
binding on and inure to the benefit of the Company and its successors and assigns, and shall be binding on Executive, his administrators, executors, legatees and heirs. In that this Agreement is a personal services contract, it shall not be assigned
by Executive. 
 5.10 Modification. This Agreement may not be and shall not be modified or amended except by written instrument signed
by the parties hereto. 
  

 Page 10 – EXECUTIVE SEVERANCE AGREEMENT 
       [Executive’s Name] 

 5.11 Entire Agreement. Except as expressly stated in this Agreement, this Agreement constitutes
the entire agreement and understanding between the parties hereto in reference to all the matters herein agreed on. This Agreement replaces and supersedes all prior agreements or understandings of the parties hereto with respect to the subject
matter hereof. 
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of the day and year
first above written. 
  

									
	EXECUTIVE	 		  	PLANAR SYSTEMS, INC.	 	
					
	  
	 		  	By:	 	  
	 	
		 		  		 	Gerry Perkel	 	
		 		  		 	President & CEO	 	

  

 Page 11 – EXECUTIVE SEVERANCE AGREEMENT 
       [Executive’s Name] 

 EXHIBIT A 
 RELEASE OF CLAIMS 
 This Document Affects Important Legal Rights You May Have

 Please Read It Carefully Before Signing 
 For and in consideration of the severance benefits described in the Executive Employment Agreement dated as of         , 200   between Planar Systems,
Inc. (the “Company”), and                      (the “Executive”), and for other good and valuable consideration, Executive
hereby releases the Company, its divisions, affiliates, subsidiaries, parents, branches, predecessors, successors, assigns, officers, directors, trustees, employees, agents, shareholders, administrators, representatives, attorneys, insurers and
fiduciaries, past, present and future (the “Released Parties”) from any and all claims of any kind, whether in tort, contract, or under local, state or federal statute, which Executive now has or may have against the Released Parties,
whether known or unknown to Executive, by reason of facts which have occurred on or prior to the date Executive signs this Release of Claims (“Release”). Executive understands and acknowledges that this Release includes, but is not limited
to, any claim for reinstatement, re-employment, attorneys’ fees or wages, stock or stock options, or additional compensation in any form, and any claim, including but not limited to claims for breach of contract, defamation, promissory
estoppel, wrongful termination, whistleblower or other retaliation claims, and discrimination and/or harassment based on age, sex, race, religion, color, creed, disability, citizenship, national origin, military service, ancestry, sexual orientation
or any other factor protected by federal, state or local law (such as claims arising Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Civil Rights Act of 1991, the Post Civil War Civil Rights Act, the
Equal Pay Act, the Americans with Disabilities Act, the Fair Labor Standards Act, the Family Medical Leave Act of 1993, the Worker Adjustment Retraining and Notification Act (WARN); Uniformed Services Employment and Re-employment Rights Act,
Executive Order 11246, the Sarbanes-Oxley Act, all as amended) relating to Executive’s employment or association with the Company or the termination of that employment and association. 
 [* * * To be completed if Executive is over age 40 on date of termination.] In accordance with the Age Discrimination in Employment Act and Older
Workers’ Benefit Protection Act (collectively, the “Act”), Executive acknowledges that (1) he has been, and hereby is, advised in writing to consult with an attorney prior to executing this Release; (2) he is aware of
certain rights to which he may be entitled under the Act; (3) as consideration for executing this Release, Executive has received additional benefits and compensation of value to which he would otherwise not be entitled; (4) by signing
this Release, he will not waive rights or claims under the Act which may arise after the execution of this Release; (5) Executive has been given a period of at least 21 days to consider this offer; (6) in the event Executive has not
executed this Release on or before                     , the offer shall expire; (7) in the event Executive signs the Release prior to 21
days, he does so voluntarily; (8) any changes to the terms of the Agreement, whether material or immaterial shall not re-start the 21-day consideration period; (9) Executive has a period of seven days from the date of execution in which to
revoke this Release by written notice to                     ; (10) in the event Executive does not exercise his right to revoke this
Release, the Release shall become effective on the date (the “Effective Date”) immediately following the seven-day waiting period described above. 
  

 EXHIBIT A TO EXECUTIVE SEVERANCE
AGREEMENT (Release of Claims) 
     [Executive’s Name] 

 Executive understands that by signing below he is voluntarily giving up any right that Executive may have
to sue or bring other claims against the Released Parties. Finally, Executive has not been forced or pressured in any manner whatsoever to sign this Release, and Executive agrees to all of its terms voluntarily. 
 This Release is final and binding and may not be changed or modified except in a writing signed by an authorized representative of the parties.

 The severance check(s) will be mailed to Executive’s last address on file with Company. 
  

							
	 Signature:
	 	  
	  	Date:	  	  

				
	 [Printed name]
	 	  
	  		  	

  

 EXHIBIT A TO EXECUTIVE SEVERANCE
AGREEMENT (Release of Claims) 
     [Executive’s Name]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]